Crossmark

Elexacaftor/tezacaftor/ivacaftor en adultos con fibrosis quística: resultados a 3 años en práctica clínica real

Crossref DOI link: https://doi.org/10.1016/j.medcli.2026.107448

Published Print: 2026-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Zamarrón de Lucas, Ester https://orcid.org/0000-0001-6053-7844
Crespo Catalán, Clara

Romero Campos, Belén

Sanz Sanjosé, Belén

Longás Ouzzine, María

Aponte Guevara, Cindy Stephania

Álvarez-Sala Walther, Rodolfo

Prados Sánchez, María Concepción
License Information

Text and Data Mining valid from 2026-08-01

Text and Data Mining valid from 2026-08-01

stm-asf valid from 2026-08-01

stm-asf valid from 2026-08-01

stm-asf valid from 2026-08-01

stm-asf valid from 2026-08-01

stm-asf valid from 2026-08-01
More Information

This article is maintained by: Elsevier

Article Title: Elexacaftor/tezacaftor/ivacaftor en adultos con fibrosis quística: resultados a 3 años en práctica clínica real

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2026.107448

Content Type: article

Copyright: © 2026 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.